LLY

Eli Lilly & Co
D

LLY

Arincen80/100B

Eli Lilly & Co free cash flow 1989–2026

Eli Lilly & Co's free cash flow in Q3 FY2026, the three months to 30 September 2026, was 8.22B USD, down 4.6% on the same quarter a year before. Eli Lilly & Co's free cash flow over the last twelve months was 19.66B USD, up 118.0% on the twelve months before. In fiscal year 2025 it was 8.97B USD, up 138.6% on the year before.

Last updated 10 Nov 2026 · Next report 3 Feb 2027

Free cash flow

Free cash flow · +21.0% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 202619.66B+117.95%22.74%30.64B-10.98B21.96
FY202531 Dec 20258.97B+138.62%13.77%16.81B-7.84B9.99
FY202431 Dec 20243.76B—8.35%8.82B-5.06B4.16
FY202331 Dec 2023-3.15B-168.52%-9.24%4.24B-7.39B-3.49
FY202231 Dec 20224.60B-14.61%16.12%7.59B-2.99B5.09
FY202131 Dec 20215.39B+20.51%19.02%7.37B-1.98B5.91
FY202031 Dec 20204.47B+28.35%18.22%6.50B-2.03B4.67
FY201931 Dec 20193.48B+38.97%15.61%4.84B-1.35B3.64
FY201831 Dec 20182.51B-27.40%11.66%5.52B-3.02B2.42
FY201731 Dec 20173.45B-8.17%17.28%5.62B-2.16B3.28
FY201631 Dec 20163.76B+180.86%17.71%4.85B-1.09B3.41
FY201531 Dec 20151.34B-53.73%6.71%2.96B-1.63B1.21
FY201431 Dec 20142.89B-37.68%14.75%4.46B-1.57B2.60
FY201331 Dec 20134.64B+8.94%20.08%5.74B-1.09B4.16
FY201231 Dec 20124.26B-23.12%18.85%5.30B-1.04B3.72
FY201131 Dec 20115.54B-2.27%22.82%7.23B-1.69B4.97
FY201031 Dec 20105.67B+62.91%24.57%6.86B-1.19B5.13
FY200931 Dec 20093.48B-45.18%15.94%4.34B-855.00M3.17
FY200831 Dec 20086.35B+55.90%31.16%7.30B-947.20M5.80
FY200731 Dec 20074.07B+40.51%21.85%5.15B-1.08B3.73
FY200631 Dec 20062.90B+370.85%18.47%3.98B-1.08B2.67
FY200531 Dec 2005615.50M-36.64%4.20%1.91B-1.30B0.56
FY200431 Dec 2004971.40M-49.93%7.01%2.87B-1.90B0.89
FY200331 Dec 20031.94B+106.44%15.42%3.65B-1.71B1.80
FY200231 Dec 2002939.80M-66.17%8.48%2.07B-1.13B0.87
FY200131 Dec 20012.78B-9.04%24.06%3.66B-884.00M2.55
FY200031 Dec 20003.05B+46.01%28.11%3.73B-677.90M2.79
FY199931 Dec 19992.09B-5.36%20.91%2.62B-528.30M1.89
FY199831 Dec 19982.21B+8.64%23.92%2.63B-419.90M1.97
FY199731 Dec 19972.03B+31.44%25.47%2.40B-366.30M1.80
FY199631 Dec 19961.55B+21.53%22.11%1.99B-443.90M1.39
FY199531 Dec 19951.27B+33.22%18.83%1.82B-551.30M1.08
FY199431 Dec 1994955.80M+8.20%16.73%1.53B-576.50M0.82
FY199331 Dec 1993883.40M+83.51%13.69%1.52B-633.50M0.74
FY199231 Dec 1992481.40M+329.06%7.81%1.48B-1.00B0.41
FY199131 Dec 1991112.20M-75.98%1.96%1.25B-1.14B0.10
FY199031 Dec 1990467.10M-2.30%9.00%1.47B-1.01B0.41
FY198931 Dec 1989478.10M—11.45%1.03B-554.50M0.41

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about Eli Lilly & Co's free cash flow

Source: Financial Modeling Prep